TherapeuticsMD
TXMD
#10751
Rank
A$29.21 M
Marketcap
A$2.52
Share price
1.75%
Change (1 day)
21.51%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2023 (TTM): A$6.79

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is A$0.12. In 2022 the company made an earnings per share (EPS) of A$18.21 an increase over its 2021 EPS that were of A-$31.48.

EPS history for TherapeuticsMD from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$6.79-62.73%
2022A$18.21-157.83%
2021A-$31.48-35.22%
2020A-$48.60-5.63%
2019A-$51.5020.34%
2018A-$42.8055.26%
2017A-$27.57-19.15%
2016A-$34.09-6%
2015A-$36.2742.86%
2014A-$25.3952.17%
2013A-$16.68-41.03%
2012A-$28.29-93.62%
2011A-$443.62-65.57%
2010A-$1,28888.66%
2009A-$682.94-32.78%
2008A-$1,01616.59%
2007A-$871.4426.96%
2006A-$686.39-11743.27%
2005A$5.90-101.88%
2004A-$313.41-554.77%
2003A$68.92216.55%
2002A$21.77-85.01%
2001A$145.24369.94%
2000A$30.91404.51%
1999A$6.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.10 850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.18 4,363.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
A-$5.61-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
A$2.72 2,244.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
A-$36.68-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA